Ablacon
is a Colorado-based AI firm that designs and develops an atrial fibrillation system to analyze and visualize electrographic flow within the cardiac chambers... Read moreAblacon
is a Colorado-based AI firm that designs and develops an atrial fibrillation system to analyze and visualize electrographic flow within the cardiac chambers... Read more
News
Feb 03, 2023
StreetInsider
Press Release: Ablacon : The FLOW-AF multicenter, randomized controlled trial shows Ablacon's Electrographic Flow (EGF) Mapping software (Ablamap) results in improved ablation outcomes in persistent atrial fibrillation
Jun 22, 2021
PR Newswire
Press Release: Ablacon : Ablacon Announces Martin Grasse as CEO and Clinical Study Progress
Jan 07, 2021
MarketScreener
Ablacon: Ablacon, Inc. : Announces $30 Million Series B Financing and Expansion of Scientific Advisory Board
Jun 23, 2020
MarketScreener
Ablacon: Ablacon, Inc. : Announces the Formation of Scientific Advisory Board
Sep 10, 2019
PR Newswire
Press Release: Ablacon : Ablacon Announces Release of New and Improved Ablamap Technology Under Existing CE Mark
Aug 02, 2019
FinSMEs
Ablacon: Ablacon Enters Into $10m Venture Debt Facility with WTI
Jul 23, 2019
BioSpace
Ablacon: Ablacon Announces Closing of a $10 Million Venture Debt Facility and $2 Million Equity Investment from Western Technology Investment; Josef Koblish and Melissa Kong to Join the Company
Jun 18, 2019
PR Newswire
Press Release: Ablacon : Ajax Health Raises an Additional $15 million, for a Total of More Than $100 million, to Close Out Ajax II
May 14, 2019
Pulse2.0
Ablacon: How Ablacon Treats Atrial Fibrillation With AI
Ablacon Competitors
1
2
3
4
5
6
7
8
9
10